Dr. Andrea Madrigrano, MD

Dr. Madrigrano practices at Rush University Medical Center in Chicago, Illinois, part of Rush System for Health.

Dr. Madrigrano's NPI, 1912198706, was assigned on August 6, 2007. Dr. Madrigrano graduated from University of Illinois College of Medicine - Chicago in 2001. Dr. Madrigrano holds Illinois license 036110335.

Dr. Madrigrano's primary practice is Rush University Medical Center, at 1653 West Congress Parkway, Chicago, IL 60612 in Cook County. The practice phone is (312) 942-5000.

Dr. Madrigrano's primary practice is Rush University Medical Center in Chicago, Illinois, part of Rush System for Health. Dr. Madrigrano is also affiliated with Rush Oak Park Hospital. The medical group on file is Rush University Internists. Dmand AI also links Dr. Madrigrano to 3 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Madrigrano practices, 5 sites in all. Vendor and product names are available with a free account.

Surgery is Dr. Madrigrano's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dr. Madrigrano is board certified in surgery by the American Board of Surgery. Dmand AI has Dr. Madrigrano's licenses on file in 2 states: Illinois and California.

Dmand AI lists breast reconstruction, breast surgery and mastectomy among the conditions Dr. Madrigrano treats.

CMS data shows 305 Medicare services from Dr. Madrigrano across 10 procedure codes in 2024, for 182 Medicare patients. Medicare paid $45,147 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 182 Medicare patients who saw Dr. Madrigrano in 2024. The largest group is 65 to 74, with 99 patients. 75% of them have cancer, and 75% have high cholesterol. 13% are also on Medicaid. Their average risk score is 1.11, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Madrigrano's median patient age at 68, with 97% women.

In 2024, Dr. Madrigrano wrote 42 Medicare Part D claims for 30 patients. 100% of them were for generic drugs. CMS names the drug for 20 of them, across 1 drug with 11 or more claims each, at $28 in total drug cost. In 2023, CMS named 19 claims across 1 drug.

Dr. Madrigrano accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 14 procedures of mastectomy by Dr. Madrigrano, more than 70% of the clinicians it reports for that procedure.

Dmand AI links 24 papers to Dr. Madrigrano, published from 2015 to 2024. 2023 was the busiest year, with 5. The most frequent topics are Breast Neoplasms, Mastectomy and Sentinel Lymph Node Biopsy. Dr. Madrigrano has published most often in J Surg Res. Dr. Madrigrano's most frequent co-authors are Katherine Anne Kopkash, MD, Alison Carol Coogan and Chandler Scott Cortina, MD.

CMS Open Payments shows 16 general payments to Dr. Madrigrano from 4 drug and device companies from 2020 to 2025. Consulting fees make up the largest share, 87% of the total. Merit Medical Systems Inc paid the most, $12,916.

Dmand AI lists 4 awards for Dr. Madrigrano, most recently Castle Connolly Top Doctor in 2020.

Dr. Madrigrano graduated from University of Illinois College of Medicine - Chicago in 2001. Dr. Madrigrano is a member of ACS and ASBS.

Dr. Madrigrano is in network with 17 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.